Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-01-15 00:00:00 ET · period of report 2026-01-15 · accession 0001231589-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-01-15 | 2026-01-15 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $469.89 | -8,300 | 42.3K | -16% | -$3.90M |
| DT | 2026-01-15 | 2026-01-15 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 45.1K | +23% | +$1.21M |
| DT | 2026-01-15 | 2026-01-15 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -8,300 | 58.4K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-15 | S | D | 3,531 | $469.34 | 38,397 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $468.84 to $469.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-01-15 | S | D | 407 | $472.28 | 41,928 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $472.13 to $472.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-01-15 | S | D | 40 | $474.74 | 36,781 | D | — | — | |
| 4 | Common | Common Stock | 2026-01-15 | S | D | 1,439 | $468.32 | 43,642 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $467.815 to $468.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-01-15 | M | A | 8,300 | $146.03 | 45,081 | D | — | — | |
| 6 | Common | Common Stock | 2026-01-15 | S | D | 1,576 | $471.44 | 36,821 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $471.00 to $471.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-01-15 | S | D | 1,307 | $470.37 | 42,335 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $469.92 to $470.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Derivative | Stock Option | 2026-01-15 | M | D | 8,300 | $0.00 | 58,400 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,300 Common Stock |